CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 73 enrolled
Drug / intervention
Mirabilis High-Intensity Focused Ultrasound Treatment Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01946178
NCT01946178N/ACompleted

Clinical Study of a Focused Ultrasound Device for Treating Uterine Fibroids and Menorrhagia

Mirabilis Medica, Inc.·interventional·Posted Sep 19, 2013·Updated May 30, 2017

In Brief

A clinical study evaluating Mirabilis High-Intensity Focused Ultrasound Treatment System for Uterine Fibroids (Leiomyomas). Completed, enrolled 73 participants across 2 sites.

Detailed Summary

The Mirabilis High-Intensity Focused Ultrasound (HIFU) Treatment System delivers therapeutic focused ultrasound energy to the uterus under integrated ultrasound imaging guidance to offer non-invasive treatment for uterine fibroids. The purpose of this clinical study is to assess the initial safety and performance of the Mirabilis HIFU Treatment System for transabdominal treatment of uterine fibroids in eligible women who are scheduled to undergo hysterectomy following treatment with the device or who are seeking relief from fibroid-related symptoms.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesMexico
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 19, 2013
Enrollment StartJan 1, 2011
Primary CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 12.8 years ago

Interventions

Mirabilis High-Intensity Focused Ultrasound Treatment Systemdevice

The intervention consists of a treatment session with the device, during which focused ultrasound energy is applied across the intact abdominal wall to ablate appropriately selected uterine fibroids under ultrasound imaging guidance.